To address the relevance of these findings in human ovarian CCC, we evaluated whether ERBB2 amplification is more prevalent in solid peritoneal metastases than primary ovarian tumors in a large cohort of unmatched CCC tumors. This evidence concerns the gene ERBB2 and ovarian neoplasm.